About Green Park & Golf Ventures
Green Park & Golf Ventures is a venture capital firm founded in 2011. It is primarily based out of Dallas, United States. As of Jun 2025, Green Park & Golf Ventures has invested in 81 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series A round of Vellum Health Overall, Green Park & Golf Ventures portfolio has seen 5 IPOs and 14 acquisitions including key companies like Validic, Lantern Pharma and Savara Pharma. A lot of funds co-invest with Green Park & Golf Ventures, with names like Capital Factory sharing a substantial percentage of its portfolio. Green Park & Golf Ventures has team of 5 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Green Park & Golf Ventures' List of Top Investments
Green Park & Golf Ventures has a portfolio of 81 companies. Their most notable investments are in PuraCath Medical and MicroTransponder.Their portfolio spans across United States, Germany and United Kingdom. They have invested in Life Sciences, Enterprise Applications, HealthTech and 21 other sectors, across stages such as Seed, Series A and 3 more. Here is the list of top investments by Green Park & Golf Ventures:
Provider of a suite primary care platform for providers. The platform allows patients to connect with healthcare experts through video calls/text messaging. Users can seek medical guidance and receive personalized treatment through online consultations with doctors. Also, it provides home-based diagnostic/lab test solutions for patients. It allows customers to know the specific genes responsible for causing disease. Also, it provides services to healthcare providers, organizations, and payers.
Key facts about Recuro Health
- Founded Year: 2021
- Location: Richardson (United States)
- Stage: Series B
- Total Funding till date: $89.3M
- Employee Count: 154 as on Aug 31, 2026
- Investors: Arch Venture Partners, Ropart Asset Management Funds and 8 Others
- Latest Funding Round: Series B, Apr 11, 2023, $*****
- Highlight: Editors' Pick
2. Mission Bio
Provider of a single-cell multi-omics platform for genotypic and phenotypic analysis. The company's proprietary Tapestri platform enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins for the precise treatment of cancer. Also, it offers DNA & protein panels, and Pharma Assay Development (PAD) Services.
Key facts about Mission Bio
- Founded Year: 2014
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $120M
- Employee Count: 90 as on Sep 30, 2026
- Investors: Mighty Capital, Ally Bridge Group and 29 Others
- Latest Funding Round: Series C, Aug 05, 2025, $*****
- Highlight: Editors' Pick
3. Validic
Provider of a single platform that aggregates data from multiple health device connections. It is a cloud-based technology platform that connects patient-recorded data from digital health applications, devices, and wearables to key healthcare companies like hospital systems, providers, pharmaceutical companies, payers, health information technology platforms, health clubs, and wellness companies.
Key facts about Validic
- Founded Year: 2010
- Location: Durham (United States)
- Stage: Acquired
- Total Funding till date: $31.6M
- Employee Count: 46 as on Sep 30, 2026
- Investors: Kaiser Permanente Ventures, Wilmington Investor Network and 14 Others
- Latest Funding Round: Series B, Nov 14, 2022, $*****
- Highlight: Acquired
Developer of neuromodulation therapy for neurological conditions. The company uses proprietary technology and product- microtransponder's product is the Vivistim Paired VNS System, for helping stroke survivors regain upper limb motor function after their stroke.
Key facts about MicroTransponder
- Founded Year: 2007
- Location: Dallas (United States)
- Valuation: $*****
- Stage: Series F
- Total Funding till date: $180M
- Employee Count: 259 as on Sep 30, 2026
- Investors: Gilde Healthcare, Longitude Capital and 11 Others
- Latest Funding Round: Series F, Mar 05, 2025, $*****
- Highlight: Editors' Pick
5. Alto
App-based for booking ride hailing services. Users can book rides through the platform by providing location, destination, user details, payment details, preferred dates, and more. The app is available for both Android and iOS devices.
Key facts about Alto
- Founded Year: 2018
- Location: Dallas (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2023
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $61.8M
- Employee Count: 479 as on Sep 30, 2026
- Investors: Franklin Templeton Investments, Frog Capital and 8 Others
- Latest Funding Round: Conventional Debt, Mar 14, 2025, $*****
- Highlight: Editors' Pick
Green Park & Golf Ventures' Year-on-Year Investment Trends
Green Park & Golf Ventures has invested in 81 companies over the last 14 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 4 investments. Its most recent first time investment was in Vellum Health and most recent follow-on round was in MicroTransponder.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 3 | 1 | 4 |
2024 | 0 | 1 | 1 |
2023 | 0 | 2 | 2 |
2022 | 3 | 2 | 5 |
2021 | 7 | 0 | 7 |
2020 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2018 | 4 | 2 | 6 |
2017 | 1 | 1 | 2 |
Green Park & Golf Ventures' Investments by Stage
Green Park & Golf Ventures has made 15 investments in Seed stage with an average round size of $1.46M, 11 investments in Series A stage with an average round size of $4.61M, 9 investments in Series B stage with an average round size of $15.9M, 2 investments in Series C stage with an average round size of $3.39M and 1 investment in Conventional Debt stage.Stage of entry | No. of Investments |
|---|---|
Seed | 15 |
Series A | 11 |
Series B | 9 |
Series C | 2 |
Conventional Debt | 1 |
Note: We have considered here, only first round of investments
Green Park & Golf Ventures' Investments by Sector
Green Park & Golf Ventures has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, High Tech and Vertical SaaS. Notably, it has invested in 73 Tech companies, 68 Enterprise (B2B) companies, 39 Software companies and at least 16 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 19 |
Enterprise Applications | 15 |
HealthTech | 11 |
High Tech | 6 |
Vertical SaaS | 6 |
Others | 28 |
Note: We have considered here, only first round of investments
Green Park & Golf Ventures' Investments by Geography
Green Park & Golf Ventures has made most investments in United States (36), followed by Germany where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 36 |
Germany | 1 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Green Park & Golf Ventures' recent investments
Green Park & Golf Ventures has not made any investment in 2026 so far.Here are the most recent investments by Green Park & Golf Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 26, 2025 | United States | Series A | 4836 | ||
Apr 22, 2025 | United States | Seed | 6408 | [+2] | |
Mar 05, 2025 | United States | Series F | 3940 | [+6] | |
Feb 03, 2025 | United States | Series A | 7316 | [+4] | |
Feb 27, 2024 | United States | Seed | 2635 |
IPOs and Publicly Listed companies in Green Park & Golf Ventures' Portfolio
5 of Green Park & Golf Ventures' portfolio companies have become public. Lantern Pharma got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2020 at marketcap of $93.3M and Atreca got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $455M.Here are Green Park & Golf Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 11, 2020 | Feb 26, 2015 | Seed | 6546 | |
Jun 20, 2019 | - | - | 4099 | |
Jul 27, 2018 | - | - | 1366 | |
Apr 27, 2017 | - | - | 2973 | |
- | - | - | 7635 |
Acquired companies in Green Park & Golf Ventures' Portfolio
14 companies from Green Park & Golf Ventures' portfolio have been acquired. The most recent acquisition was Validic in Jun 2026 by ChartSpan for $*****.Here are Green Park & Golf Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 22, 2026 | Nov 14, 2022 | Series B | 6370 | |
Jan 16, 2026 | - | - | 7074 | |
Aug 22, 2023 | Nov 30, 2018 | Series A | 9465 | |
Jul 29, 2022 | Mar 24, 2016 | Series B | 9693 | |
Dec 20, 2021 | Jul 2013 | Seed | 4730 |
Team profile of Green Park & Golf Ventures
Green Park & Golf Ventures has a team of 5 members including 4 Partners and 1 Principal located in United States. Green Park & Golf Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Green Park & Golf Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Dallas | - | ||
Partner | Dallas | - | ||
Partner | Austin | - | - | |
Partner | Dallas | - | ||
Principal | Houston | - |
Co-investors of Green Park & Golf Ventures
Over the past 14 years, 157 investors have co-invested in Green Park & Golf Ventures's portfolio companies. This includes funds and angels.
- Invested before Green Park & Golf Ventures: HHS, Health Wildcatters and 46 others have invested in rounds before Green Park & Golf Ventures. There are 8 companies where HHS has invested before Green Park & Golf Ventures and 4 companies where Health Wildcatters has invested before Green Park & Golf Ventures.
- Top Co-investors of Green Park & Golf Ventures: 63 investors entered a company along with Green Park & Golf Ventures. These include investors like Capital Factory (3 companies).
- Invested after Green Park & Golf Ventures: A total of 46 investors have invested in Green Park & Golf Ventures's portfolio after their investments. Top Investors include Perot Jain (2 companies), NIH (2 companies) and Flippen Group (1 company).
Recent News related to Green Park & Golf Ventures
•
•
Vellum Health Secures Series A Funding Led by FCA Venture Partners and Launches Mobile IV Care Platformintelligence360•Jul 01, 2025•Vellum, FCA Venture Partners, Green Park & Golf Ventures
•
MicroTransponder receives $65m to advance stroke care with VivistimMedicalDeviceNetwork•Mar 13, 2025•MicroTransponder, Usventure, Exceller Hunt, Green Park & Golf Ventures and 6 others
•
MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke RecoveryPR Newswire•Mar 12, 2025•MicroTransponder, Usventure, USVP, Osage Partners and 7 others
•
Affineon Health Raises $5M for AI-Powered Physician Inbox ManagementHIT Consultant•Feb 05, 2025•Affineon, Green Park & Golf Ventures, Headwater Ventures, Benhamou Global Ventures and 2 others
•
Prolocor Announces $1.7 Million in Bridge FundingNewswire•Feb 27, 2024•Prolocor, Green Park & Golf Ventures, LabCorp
•
Claire England Leads GPG Ventures’ Austin Office Focused on HealthcareOct 01, 2023•Green Park & Golf Ventures
•
Recuro Health Closes $47 Million Series B Financing Led by ARCH Venture Partners, Advancing Innovative Virtual-First Care ServiceBusiness Wire•Apr 11, 2023•Recuro Health, Arch Venture Partners, Flippen Group, Green Park & Golf Ventures and 2 others
•
Industrial Metaverse Platform Worlds Raises $21M in Series A1 FundingNftgators•Jan 09, 2023•Worlds, Moneta Ventures, Align Capital Partners, Green Park & Golf Ventures and 5 others
•
Validic Inc. raises $12 million in its latest funding roundPR Newswire•Nov 14, 2022•Validic, Kaiser Permanente Ventures, Arkin Holdings, Green Park & Golf Ventures and 5 others
